Catheter treatment to remove blood clots in the lungs
Treatments studied
Part of Heart & circulation, Lungs & breathing clinical trials.
This Phase 3 trial tests a catheter-based procedure to remove a lung blood clot (pulmonary embolism) and reduce strain on the heart. It may help people who have specific CT scan signs of right-heart strain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older
- Your CT scan with dye shows a lung blood clot in a main or large branch artery
- Your CT scan also shows right-heart strain (right-heart size is bigger than the left)
- Your symptoms started within the last 14 days for this episode
- Your blood pressure is stable (not in severe shock; no strong BP medicines needed right now)
- You can safely receive clot-busting medicine (rt-PA) and contrast dye, or your allergy can be managed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called the FlowTriever to remove blood clots from the lungs in people with a pulmonary embolism that is not too severe. The goal is to see if this treatment can help improve heart function and symptoms without major surgery.
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
This trial tests a treatment that uses ultrasound to guide a thin tube (catheter) to deliver clot-busting medicine directly into the blood clot in your lung. It may be an option for people whose clot is serious but not yet causing shock, and who have symptoms that started within the last two weeks.
This study looks at how well different treatments work for a blood clot in the lung (pulmonary embolism). It includes people who are getting or have already gotten a clot-dissolving medicine or a catheter procedure to remove the clot.
This trial tests a device that removes blood clots from the lungs in people with a recent pulmonary embolism. It may help improve blood flow and reduce strain on the heart.
This trial compares three treatments for an intermediate-high risk pulmonary embolism: a minimally invasive clot removal procedure (embolectomy), a low-dose clot-dissolving medication, or standard blood thinning (heparin). The goal is to see which approach works best to prevent worsening while reducing bleeding risks.
Hear when a new Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.